综合数据在欧洲监管决策中的作用
Clara Alloza1, Bethany Knox1, Hanaya Raad1
1Aetion, Inc., New York, New York, USA.
Clinical pharmacology and therapeutics
|July 13, 2023
概括
综合数据为欧洲的健康数据挑战提供了创新的解决方案,解决了隐私和监管障碍. 为了使研究人员和监管机构广泛采用,需要进一步开发.
科学领域:
- 健康数据科学健康数据科学
- 监管科学是一种监管科学.
- 数据隐私 数据隐私
背景情况:
- 欧盟在使用健康数据方面面临重大挑战,包括隐私,碎片化,有效性和可概括性.
- 严格的法规,高成本和时间限制阻碍了欧洲的患者数据共享,延迟了证据生成和监管批准.
- 人工生成的合成数据正在成为医疗研究中的真实世界数据 (RWD) 的替代品.
研究的目的:
- 审查合成数据在欧洲监管环境中的决策方面的潜在优点和挑战.
- 探索目前的应用和正在进行的倡议,涉及到医疗保健中的合成数据.
- 评估合成数据在监管目的中的价值,并确定其采用障碍.
主要方法:
- 在医疗保健研究中合成数据应用的文献综述.
- 分析欧盟关于数据使用的监管格局和举措.
- 检查在欧洲医疗保健中采用合成数据的障碍和机会.
主要成果:
- 综合数据提供了创新的解决方案,以克服欧洲卫生数据使用中的隐私和监管障碍.
- 尽管有越来越多的兴趣和倡议,但现实的障碍阻碍了欧洲研究人员和监管机构充分采用合成数据.
- 越来越多地使用RWD和合成数据,需要为证据生成和决策制定监管框架.
结论:
- 合成数据对推进欧洲的医疗保健研究和监管过程具有重大前景.
- 解决实际挑战对于将合成数据成功整合到欧洲监管框架中至关重要.
- 鉴于人工智能,机器学习和数据生成的进步,对合成数据的持续探索至关重要.
更多相关视频
00:05In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
14.0K
09:34Implementation of Portable Emissions Measurement Systems PEMS for the Real-driving Emissions RDE Regulation in Europe
Published on: December 4, 2016
28.2K
相关概念视频
01:28Global Regulatory Systems
44
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
44
01:03Drug Control Governance: Regulatory Bodies and Their Impact
189
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
189
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
02:02Cis-regulatory Sequences
9.9K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
9.9K
01:19Pharmacovigilance
901
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
901
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148